PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study shows MeMed's blood test accurately distinguishes bacterial and viral infections

Large study in PLOS ONE shows MeMed's ImmunXpert immune system-based test could help improve management of infections and reduce drug resistance due to antibiotic overuse

2015-03-18
(Press-News.org) Tirat Carmel, Israel - March 19, 2015 - MeMed, Ltd., today announced publication of the results of a large multicenter prospective clinical study that validates the ability of its ImmunoXpert in-vitro diagnostic blood test to determine whether a patient has an acute bacterial or viral infection. The study enrolled more than 1,000 patients and is published in the March 18, 2015 online edition of PLOS ONE. Unlike most infectious disease diagnostics that rely on direct pathogen detection, MeMed's assay decodes the body's immune response to accurately characterize the cause of the infection.

Bacterial and viral infections are often clinically indistinguishable, leading to antibiotic overuse and contributing to the spread of antibiotic resistance, which the World Health Organization says is approaching crisis proportions. Paradoxically, the inability to rapidly differentiate infections also results in the underuse of antibiotics, estimated to occur in 20-40% of all bacterial infections, putting patients at risk of complications and increasing healthcare costs. MeMed researchers developed the ImmunoXpert test to accurately distinguish between bacterial and viral infections, with the goal of improving patient management by providing physicians with information that enables them to reduce both the overuse and underuse of antibiotics.

Eran Eden, PhD, CEO of MeMed, noted, "Antibiotic misuse is a pressing public health concern, with devastating healthcare and economic consequences. Rapid, accurate and actionable diagnostic tools are an important part of the solution because they can aid physicians in making better informed treatment decisions. For the past four years, our team has been collaborating with leading clinicians and scientists from around the world to develop and validate our novel approach for distinguishing between bacterial and viral infections. Unlike most traditional diagnostics, this approach builds on an exquisitely informative system crafted by nature - the human immune system. Our scientists have figured out how to decode the actions of the immune system doing what it does best--detecting and responding to the precise cause of infection."

MeMed's technology leverages the fact that bacteria and viruses trigger different pathways in the immune system. By conducting extensive screening of immune system proteins in patients with acute infections, researchers identified three soluble proteins that are uniquely activated by bacteria or viruses. They then developed proprietary algorithms that integrate these proteins to produce an immune signature that accurately identifies the cause of infection.

In the PLOS ONE study, the ImmunoXpert immune signature was developed and independently validated on a cohort of 1002 patients with acute infections and yielded highly accurate results, with sensitivity and specificity greater than 90%. The assay was validated in a diverse group of pediatric and adult patients at different time points after the onset of symptoms (from the first day up to 12 days) and across 56 different pathogen species. ImmunoXpert remained robust over all sub-groups studied. The predictive power of the assay's immune signature outperformed routine biomarker and laboratory tests, as well as combinations of these tests. The signature is amenable to rapid measurement using a blood test run on standard hospital and laboratory-deployed automated platforms, or using a point-of-care device now in development.

"We conducted big data filtering, followed by extensive screening of 600 immune system-related proteins," said Kfir Oved, PhD, MeMed CTO. "A few of the proteins showed distinctly different patterns in bacterial and viral infected patients. In particular, the most informative protein we found, called TRAIL, dramatically increased in the blood of patients infected with a wide range of viruses, but surprisingly, decreased in bacterial infections. Our team developed an algorithm that computationally integrates TRAIL with other immune proteins to diagnose the cause of the infection with high accuracy."

The ImmunoXpert immune-based approach overcomes inherent limitations of many traditional diagnostics tools. It is accurate and rapid, it can diagnose infections that are not readily accessible such as pneumonia (because immune system components circulate throughout the entire body), and it prevents false alarms due to the benign presence ("carriage") of potentially pathogenic bacteria and viruses that are not causing active disease.

"This study represents a breakthrough in our efforts to develop more accurate, rapid and actionable diagnostic tools that improve the management of patients with acute infection." said Professor Isaac Srugo, MD, Head of the Pediatric Department and Microbiology Lab at Bnai Zion Medical Center. "The incorporation of novel viral-induced proteins, currently not in clinical use, enables ImmunoXpert to attain high levels of accuracy, which can help physicians make better informed antibiotic treatment decisions. This should result in more bacterial infected patients receiving timely therapy that is actually useful for treating their illness. Additionally, it can lead to fewer prescriptions to viral patients for whom antibiotics do nothing to speed recovery, while causing potential harm to the larger community."

MeMed's ImmunoXpert test is CE marked and approved for clinical use in the European Union and Israel. It is currently in pilot distribution in these territories, with a broader commercial roll-out planned for later this year. Additional clinical studies are underway and the company is planning to conduct clinical trials in the U.S. using a specially-designed point-of-care platform currently in development.

INFORMATION:

About MeMed MeMed is dedicated to improving patient lives through research, development and commercialization of pioneering products that monitor the body's immune state. Its products decode the immune system's distinct responses to different health and disease states. The company focuses on providing rapid, accurate and actionable diagnostic solutions for acute infectious diseases and inflammatory disorders in the hospital and community. Its most advanced product, ImmunoXpertTM, has demonstrated the ability to accurately detect whether a patient has a bacterial or viral infection, with the aim of empowering physicians to make better informed antibiotic treatment decisions. ImmunoXpert is CE marked and approved for clinical use in the EU and Israel, with pilot distribution efforts underway. For additional information, please visit http://www.me-med.com.

Notes to Editors For more information on the public health crisis caused by the spread of antibiotic resistant bacteria, see for example: Laxminarayan R. et al. Antibiotic resistance--the need for global solutions. Lancet Infect Dis. 2013 (http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970318-9/abstract) Threat Report 2013, Antimicrobial Resistance, CDC. http://www.cdc.gov/drugresistance/threat-report-2013/ Fauci and Marston. The Perpetual Challenge of Antimicrobial Resistance. JAMA 2014 (http://jama.jamanetwork.com/article.aspx?articleid=1851734) For more information on antibiotic underuse, see: Craig JC, et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ. 2010 (http://www.bmj.com/content/340/bmj.c1594) Houck PM. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med. 2004 (http://archinte.jamanetwork.com/article.aspx?articleid=216850



ELSE PRESS RELEASES FROM THIS DATE:

Amazon's carbon uptake declines as trees die faster

Amazons carbon uptake declines as trees die faster
2015-03-18
The most extensive land-based study of the Amazon to date reveals it is losing its capacity to absorb carbon from the atmosphere. From a peak of two billion tonnes of carbon dioxide each year in the 1990s, the net uptake by the forest has halved and is now for the first time being overtaken by fossil fuel emissions in Latin America. The results of this monumental 30-year survey of the South American rainforest, which involved an international team of almost 100 researchers and was led by the University of Leeds, are published today in the journal Nature. Over recent ...

Structure of genetic messenger molecules reveals key role in diseases

2015-03-18
Messenger RNAs (mRNA) are linear molecules that contain instructions for producing the proteins that keep living cells functioning. A new study by UCL researchers has shown how the three-dimensional structures of mRNAs determine their stability and efficiency inside cells. This new knowledge could help to explain how seemingly minor mutations that alter mRNA structure might cause things to go wrong in neurodegenerative diseases like Alzheimer's. mRNAs carry genetic information from DNA to be translated into proteins. They are generated as long chains of molecules, but ...

Who do you think you really are? The first fine-scale genetic map of the British Isles

2015-03-18
Many people in the UK feel a strong sense of regional identity, and it now appears that there may be a scientific basis to this feeling, according to a landmark new study into the genetic makeup of the British Isles. An international team, led by researchers from the University of Oxford, UCL (University College London) and the Murdoch Childrens Research Institute in Australia, used DNA samples collected from more than 2,000 people to create the first fine-scale genetic map of any country in the world. Their findings, published in Nature, show that prior to the mass ...

How planthoppers got their wings

How planthoppers got their wings
2015-03-18
DURHAM, N.C. -- Each year, rice in Asia faces a big threat from a sesame seed-sized insect called the brown planthopper. Now, a study reveals the molecular switch that enables some planthoppers to develop short wings and others long -- a major factor in their ability to invade new rice fields. The findings will appear Mar. 18 in the journal Nature. Lodged in the stalks of rice plants, planthoppers use their sucking mouthparts to siphon sap. Eventually the plants turn yellow and dry up, a condition called "hopper burn." Each year, planthopper outbreaks destroy hundreds ...

Antibiotic resistance linked to corruption: ANU media release

2015-03-18
Researchers have linked antibiotic resistance with poor governance and corruption around the world. Lead researcher Professor Peter Collignon from The Australian National University (ANU) School of Medicine said the increase in antibiotic-resistant infections was one of the greatest threats facing modern medicine. In the United States alone, around 23,000 deaths and two million illnesses each year have been attributed to antibiotic-resistant bacteria. "We found poor governance and higher levels of corruption are associated with higher levels of antibiotic resistance," ...

Researchers identify protein needed for repair of injured kidney cells

2015-03-18
COLUMBUS, Ohio - Cardiovascular researchers at The Ohio State University Wexner Medical Center have shown that a protein known as MG53 is not only present in kidney cells, but necessary for the organ to repair itself after acute injury. Results from this animal model study are published in the journal Science Translational Medicine. Previous work by Jianjie Ma, a professor and researcher in Ohio State's Department of Surgery and the Dorothy M. Davis Heart & Lung Research Institute, identified and proved that MG53 repairs heart, lung and skeletal muscle cells as well. "MG53 ...

Location, location, location: Bike-sharing systems need revamp to attract more riders

2015-03-18
Although bike-sharing systems have attracted considerable attention, they are falling short of their potential to transform urban transportation. A new study by University of Chicago Booth School of Business Assistant Professor Elena Belavina, INSEAD Professor of Sustainable Development Karan Girotra and INSEAD Ph.D. candidate Ashish Kabra found that it is possible for cities to increase ridership without spending more money on bikes or docking points -- simply by redesigning the network. The researchers spent four months in Paris observing the Velib' bike-share system ...

Doctors say women with aytpia or DCIS should seek second opinions after breast biopsies

2015-03-18
While doctors almost always agree on a pathological diagnosis of invasive breast cancer, there is room for improvement when diagnosing atypia (or atypical ductal hyperplasia-ADH) and DCIS (ductal carcinoma in-situ), Anna Tosteson, ScD and Tracy Onega, PhD from Dartmouth-Hitchcock's Norris Cotton Cancer Center have found. The Dartmouth investigators, and national collaborators, published the study, "Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens," today in JAMA. "About 1.6 million breast biopsies are done every year in the U.S., yet in nearly ...

Low vitamin D levels and depression linked in young women, new OSU study shows

Low vitamin D levels and depression linked in young women, new OSU study shows
2015-03-18
CORVALLIS, Ore. - A new study from Oregon State University suggests there is a relationship between low levels of vitamin D and depression in otherwise healthy young women. OSU researchers found that young women with lower levels of vitamin D were more likely to have clinically significant depressive symptoms over the course of a five-week study, lead author David Kerr said. The results were consistent even when researchers took into account other possible explanations, such as time of year, exercise and time spent outside. "Depression has multiple, powerful causes ...

mHealth app ideal for breast cancer risk assessment, prevention

2015-03-18
Interviewing women at a breast-imaging center in an urban safety net institution before and after they used a "mHealth" mobile health app on a tablet, Elissa Ozanne, PhD from Dartmouth's Norris Cotton Cancer Center and colleagues concluded that older, diverse, and low income women found it easy to use and acceptable. Published in the Journal of Health Disparities Research Practices, the paper with these findings is "Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income ...

LAST 30 PRESS RELEASES:

DNA aptamer drug sensors can instantly detect cocaine, heroin and fentanyl – even when combined with other drugs

New project will use next-gen at-home rapid test to track COVID-19, RSV, and flu

SRI relaunches the PARC Forum event series as it celebrates the first anniversary of acquiring the storied Palo Alto Research Center

An inside look at Beech tree disease

New AI model draws treasure maps to diagnose disease

Breastfeeding after COVID-19 booster can give babies antibodies

Researchers closing in on genetic treatments for hereditary lung disease, vision loss

COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection

UC Irvine receives $15 million NSF grant for integrative movement research

University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements

JWST captures the end of planet formation

Good news—MS drugs taken while breastfeeding may not affect child development

Programs intended to reduce health insurance premiums may make coverage less affordable for the middle class

PrEP discontinuation in a US national cohort of sexual and gender minority populations, 2017–22

USC Study: Medicare Part D plans increased restrictions on drug coverage

Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas

Global study unveils "problematic" use of porn

Newly discovered protein prevents DNA triplication

Less ice in the arctic ocean has complex effects on marine ecosystems and ocean productivity

Antarctica’s coasts are becoming less icy

New research shows migrating animals learn by experience

Modeling the origins of life: New evidence for an “RNA World”

Scientists put forth a smarter way to protect a smarter grid

An evolutionary mystery 125 million years in the making

Data science approach to identifying thermal conductivity-related structural factors in amorphous materials

Deciphering the male breast cancer genome

Detection of suicide-related emergencies among children using real-world clinical data: A free webinar from the Brain & Behavior Research Foundation

Editor-in-Chief of Sustainability and Climate Change Madhavi Venkatesan named USA TODAY Woman of the Year for Massachusetts for leading plastic bottle ban efforts

Tests show high-temperature superconducting magnets are ready for fusion

Zika vaccine safe, effective when administered during pregnancy

[Press-News.org] New study shows MeMed's blood test accurately distinguishes bacterial and viral infections
Large study in PLOS ONE shows MeMed's ImmunXpert immune system-based test could help improve management of infections and reduce drug resistance due to antibiotic overuse